772 related articles for article (PubMed ID: 15066433)
1. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
[TBL] [Abstract][Full Text] [Related]
2. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
3. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
[TBL] [Abstract][Full Text] [Related]
4. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
5. A structure-based database of antibody variable domain diversity.
Bond CJ; Wiesmann C; Marsters JC; Sidhu SS
J Mol Biol; 2005 May; 348(3):699-709. PubMed ID: 15826665
[TBL] [Abstract][Full Text] [Related]
6. Design and construction of synthetic phage-displayed Fab libraries.
Bostrom J; Fuh G
Methods Mol Biol; 2009; 562():17-35. PubMed ID: 19554284
[TBL] [Abstract][Full Text] [Related]
7. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
[TBL] [Abstract][Full Text] [Related]
8. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
[TBL] [Abstract][Full Text] [Related]
9. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
10. Comment on "Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates".
Lucas AH; Reason DC
J Immunol; 2009 May; 182(9):5160-1. PubMed ID: 19380755
[No Abstract] [Full Text] [Related]
11. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
[TBL] [Abstract][Full Text] [Related]
12. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
13. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
14. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
16. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Barrios Y; Jirholt P; Ohlin M
J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
[TBL] [Abstract][Full Text] [Related]
17. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
18. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
19. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
20. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
